3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Tumor Lysis Syndrome
4
Lymphoma
4
Leukemia
4
Hyperuricemia
4
Neoplasms
2
Recurrence
1
Nutritional and Metabolic Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Hematologic Neoplasms
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Interventions
rasburicase
1
Urate Oxidase
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nutritional and Metabolic Diseases
×
Urate Oxidase
×
Clear all
NCT00290992
2009-03-30
Rasburicase for Hyperuricemia
Sanofi
Phase 2
Completed
30 enrolled